Adult Primary Hepatocellular Carcinoma Completed Phase 2 Trials for Bortezomib (DB00188)

Also known as: Primary Adult Hepatocellular Carcinoma

IndicationStatusPhase
DBCOND0029159 (Adult Primary Hepatocellular Carcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00077441Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)Treatment
NCT00083226Doxorubicin and Bortezomib in Treating Patients With Liver CancerTreatment